RARE-29. PROGRAMMED DEATH LIGAND 1 EXPRESSION AND TUMOR INFILTRATING LYMPHOCYTES IN TUMORS ASSOCIATED WITH NEUROFIBROMATOSIS TYPE 1 AND 2

BACKGROUND: Immune checkpoint inhibitors targeting programmed cell death 1 (PD-1) or its ligand (PD-L1) have been shown to be effective in treating patients with a variety of cancers. Positive associations between clinical response rates and PD-L1 expression on tumor and immune cells, as well as the...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Wang, Shiyang, Liechty, Benjamin, Patel, Seema, Weber, Jeffrey, Hollman, Travis, Snuderl, Matija, Karajannis, Matthias
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2017
Onderwerpen:
Abstracts
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692798/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.873
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items